AmerisourceBergen Expands $8.1 Billion Contract: Providing Pharmaceutical Products for U.S. Military Through 2027
AmerisourceBergen Drug Corp., Conshohocken, Pennsylvania, has been awarded an estimated $8,092,101,497 modification (P00008) exercising the first two-year option period of a two-year base contract (SPE2DX-22-D-0051) with three two-year option periods for pharmaceutical products. This is a firm-fixed-price, requirements contract. Locations of performance are Arizona, Missouri, New Jersey, Delaware, Florida, Tennessee, Indiana and Massachusetts, with a Dec. 16, 2026, performance completion date. Using customer is Defense Health Agency. Type of appropriation is fiscal 2025 through 2027 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.
